For diseases that involve thinning of the cornea (such as keratoconus, for example, a not widely known eye disease that results in vision loss for many people), transplant-based surgeries are currently the most sought-after solution.
Worldwide, tens of millions of people are affected by cornea diseases, but only a small proportion are fortunate enough to undergo corneal transplantation. In this regard, for corneal repair, a team of researchers at the University of Ottawa has revealed that they have found great potential in an injectable biomaterial activated by pulses of low-energy blue light. The goal is to effectively thicken and remodel damaged corneal tissue.
Source: news-medical.net
If you have any doubts or questions about keratoconus and the latest treatments, contact us now here keratoconuscenter.eu/en/contacts/